Home › Blood Cancers › NCT01351545
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RecruitingObservational study
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients With Hematologic Malignancies and Other Indications
Who can join
All ages · All sexes
Full eligibility criteria
Inclusion Criteria: * Disorders affecting the hematopoietic system that are inherited, acquired, or result from myeloablative treatment * Signed informed consent (and signed assent, if applicable) obtained prior to study enrollment * Pediatric and adult patients of any age Exclusion Criteria: * Patients who are receiving only licensed CBUs * Cord blood transplant recipients at international transplant centers * Patients who are enrolled on another IND protocol to access the unlicensed CBU(s) * Patients whose selected unlicensed CBU(s) will be more than minimally manipulated
About the study
This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other indications.
What is being tested
- A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) (drug)
Sponsor: Center for International Blood and Marrow Transplant Research · Participants: 99,999 · Started: 2011-10
Contact the study team
Official record on ClinicalTrials.gov — NCT01351545
Locations in the U.S.
Conditions
- Blood Cancers
- Acute Myeloid Leukemia
- Acute Lymphoblastic Leukemia
- Chronic Myeloid Leukemia
- Hodgkin Lymphoma
- Non-Hodgkin Lymphoma
- Autoimmune Diseases
- Aplastic Anemia
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.